Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Acadia, Aribio, Ascentage, Ascletis, Biosig Technologies, Clover, Eli Lilly, Evelo, Evgen, FSD, Hua Medicine, Humanigen, Inflarx, Innovent, Kiniksa, Neuren, Remegen, Ridgeback, Sagimet.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akili, Apyx Medical, Companion Medical, Miracor Medical, Neoteryx, Preceptis Medical, Royal Philips.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Apple, Archerdx, Artegraft, Bertin Instruments, Bioskryb, Brite-Strike Technologies, Demetech, Golden Vine International, Hawkeye Systems, Illumina, Inovio Pharmaceuticals, Illumina, Invictus Medical, Invitae, Invo Bioscience, Karten Design, Lemaitre Vascular, Litecure, Mbio Diagnostics, Misty Robotics, Myocardial Solutions, Nano-X Imaging, Northeast Scientific, Ocutrx Vision Technologies, Pathgroup, Pathogendx, Qiagen, Sengenics, Transenterix, Vitanova Biomedical, Xatek, Zimmer Biomet.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Draper, Rewalk, Viewray.

Med-tech firms raising money in public or private financings, including: Brightinsight, Carlsmed.

New hires and promotions in the med-tech industry, including: Bendit Technologies, Scapa Group, Sprintray.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Immunovative, Mirror Biologics, Karuna, Karyopharm, Marker, Myovant, Novaremed, Pharmacyclics, Polynoma, Reneo, Renibus, Santhera.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aligos, Alphabet, Amgen, Avita, Biosig, Brainstorm, Catalent, CARB-X, Century Therapeutics, Daiichi Sankyo, Empirica, Everest, Frontier Scientific, Gilead, Illumina, Inovio, Itm Isotopen, Leo Lens, Linnaeus, Millendo, Miragen, Novartis, Palatin, Scenic, Schrödinger, Takeda, Teligent, Thermo Fisher Renibus, Viralclear, Wuxi Apptech.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ABM, Achilles, Bioinvent, Fibrogen, Kadmon, Myovant, Oncolytics, Oppilan, Principio, Reneo, Seelos, Sunesis, Vaccitech.

Biopharmas raising money in public or private financings, including: Castle Biosciences, Catalyst Biosciences, Greenwich Lifesciences, Iveric Bio, Leap, Outlook, Sana, Saniona, Silence, Tara Biosystems.